Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Neonatal Jaundice

Neonatal Jaundice

Dr. Subita Alagh
Written By Dr. Subita AlaghBDS
Reviewed By Dr. Rajeev Sharma
MBA, MBBS
Last updated on: 27 Sep 2022 | 06:23 PM (IST)
Overview

Neonatal jaundice or neonatal hyperbilirubinemia occurs as a result of elevated total serum bilirubin (TSB) and clinically manifests as yellowish discoloration of the skin, sclera (the white layer that covers the inner surface of the eye) and mucous membrane. This is a very common condition and is seen in about 2/3 of all healthy newborns. However, sometimes it may be a sign of feeding habits, level of hydration, or the lifespan of red blood cells (RBCs). Other rare causes can include metabolic disorders, malfunctioning of the glands, or liver disease. 

In most cases, jaundice is a mild, transient, and self-limiting condition and is referred to as "physiological jaundice." If it becomes more severe due to an underlying cause then it is called "pathological jaundice." Failure to diagnose and treat pathological jaundice may lead to the deposition of bilirubin in the brain tissues, known as kernicterus.

The treatment of choice depends on the severity of jaundice, the cause for the increase in bilirubin, or the type of bilirubin. It can vary from something as simple as increasing water intake and modifying the feeding to a very complex treatment depending on the cause.

Close TOC
Overview
Key Facts
Types
Symptoms
Causes
Risk factors
Diagnosis
Prevention
Specialist to visit
Treatment
Home-care
Complications
Alternatives therapies
Living with
FAQs
References